HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
OMER
Omeros Corporation
Healthcare Biotechnology · Washington, USA · Reports in usd
Market Cap: $882.0M
Market Cap
$882.0M
Enterprise Val
$1.06B
P/E Ratio
10.24
P/B Ratio
-13.93
Trailing PEG (1Y)
-0.04
As Of
May 14, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value-$63.3M
Gross Margin94.07%
Profit Margin94.07%
Return on Equity-54.39%
Return on Assets34.53%
Current Ratio3.03
Debt/Equity-4.90
LT Debt/Equity-4.49
Revenue Per Share0.14

Income Statement

Mar 31, 2026
Revenue$9.9M
Cost of Revenue$587.0K
Gross Profit$9.3M
R&D$13.4M
SG&A$13.4M
Operating Expenses$26.7M
Operating Income-$17.4M
Interest Expense$5.9M
Tax Expense$57.0K
Net Income$56.1M
EPS (Basic)$0.78
EPS (Diluted)$0.62
EBIT$62.0M
EBITDA$62.3M
Consolidated Income$56.1M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$1.9M
Accounts Receivable$12.0M
Inventory$183.0K
Current Assets$180.4M
LT Investments$1.1M
Property, Plant & Equipment$11.0M
Intangibles$0.00
Non-Current Assets$105.8M
Total Assets$286.2M
Accounts Payable$5.4M
Current Debt$26.3M
Current Liabilities$59.4M
LT Debt$284.4M
Non-Current Liabilities$290.1M
Total Liabilities$349.5M
Total Debt$310.6M
Retained Earnings-$857.6M
Shareholder Equity-$63.3M
Shares Outstanding71,996,171

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$14.5M
Investing Cash Flow$28.7M
Financing Cash Flow-$22.0M
CapEx$0.00
Free Cash Flow-$14.5M
Depreciation & Amort.$239.0K
Stock-Based Comp$1.9M
Acquisitions / Disposals$0.00
Investment Activity$28.7M
Debt Issued/Repaid-$21.9M
Equity Issued/Repaid-$52.0K
Dividends Paid$0.00
Net Change in Cash-$7.8M
Data cached · Meta live · Daily live · Statements live · TTL 24h